您的位置: 首页 > 2016年11月 第47卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

尼莫地平治疗无症状脑梗塞认知功能障碍的对照研究

Case control study on the effect of Nimodipine in treating cognitive impairment with silent cerebral infarction

来源期刊: 广州医药 | 36-38 发布时间:2021-12-02 收稿时间:2025/11/13 16:52:33 阅读量:25
作者:
关键词:
尼莫地平无症状脑梗塞MoCA量表
NimodipineSilent cerebral infarctionMoCA scale
DOI:
10.3969/j.issn.1000-8535.2016.06.012
收稿时间:
2016-07-26 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨尼莫地平对无症状脑梗塞认知功能障碍的改善作用及安全性。方法 将80例无症状脑梗塞患者随机分为治疗组和对照组,每组40例,于治疗前及治疗后3月分别进行蒙特利尔认知量表(MoCA)、简易智能状态量表(MMSE)、画钟测验(CDT)评估,并比较2组的评分结果。结果 尼莫地平治疗后3月MMSE 评分为(26.35±3.26)分,MoCA评分为(25.53±4.31)分,CDT评分为(6.12±2.23)分,较对照组分别为MMSE 评分为(23.12±3.45)分,MoCA评分为(22.21±3.63)分,CDT评分为(4.35±2.61)分有改善,差异均有统计学意义(P<0.05)。80例患者中MoCA评测异常组在视空间与执行能力、延迟记忆、注意力及计算力、抽象思维等分项得分明显低于MoCA评测正常组(P<0.05)。结论 尼莫地平能有效改善无症状脑梗塞患者的认知功能,且安全性较高。
Objective To explore the role of nimodipine in improving cognitive function in silent cerebral infarction patients and its safety. Methods Eighty SCI patients were divided randomly into 2 groups.MMSE、MoCA and CDT scores were assessed before treatement and after 3 month of treatment.The results were compared between the 2 groups. Results MMSE、MoCA and CDT scores of Nimodipine group(26.35±3.26, 25.53±4.31, 6.12±2.23, respectively), improved when compared with the control(23.12±3.45, 22.21±3.63, 4.35±2.61,respectively),and the difference was statistical significance (P<0.05). The patients with abnormal MoCA had lower scores in several cognitive domains (visuospatial and executive abilities, delayed memory, attention and capacity of calculation, abstract thinking (P<0.05) compared with control group. Conclusion Nimodipine could improve effectively the cognitive function in SCI patients and with a higher safety.
1、 HAAN EH, NYS GM, VAN ZANDVOORT MJ. Cognitive function following stroke and vascular cognitive impairment[J]. Curr Opin Neurol, 2006,19(5):559-564. HAAN EH, NYS GM, VAN ZANDVOORT MJ. Cognitive function following stroke and vascular cognitive impairment[J]. Curr Opin Neurol, 2006,19(5):559-564.
2、 FREITAS S, SIM?ES MR, ALVES L, et al.Montreal Cognitive Assessment (MoCA): Validation Study for Vascular Dementia[J]. Int Neuropsychol Soc, 2012,8(1):1-10. FREITAS S, SIM?ES MR, ALVES L, et al.Montreal Cognitive Assessment (MoCA): Validation Study for Vascular Dementia[J]. Int Neuropsychol Soc, 2012,8(1):1-10.
3、 胡运新,王展航. 丁苯酞软胶囊治疗脑小血管病伴发非痴呆血管性认知功能损害患者的临床研究[J]. 现代医院,2015,15(12):50-52. 胡运新,王展航. 丁苯酞软胶囊治疗脑小血管病伴发非痴呆血管性认知功能损害患者的临床研究[J]. 现代医院,2015,15(12):50-52.
4、 黄礼媛,贾建平.血管性认知障碍的研究进展[J]. 中国脑血管病杂志,2010,7(5):125-127. 黄礼媛,贾建平.血管性认知障碍的研究进展[J]. 中国脑血管病杂志,2010,7(5):125-127.
5、 中国防治认知功能障碍专家共识专家组.中国防治认知功能障碍专家共识[J]. 中华内科杂志,2006,45(2):171-173. 中国防治认知功能障碍专家共识专家组.中国防治认知功能障碍专家共识[J]. 中华内科杂志,2006,45(2):171-173.
6、 YANPALLEWAR SU,HOTA D,RAI S,et al. Nimedipine attenuates biochemi-cal, behavioral and histopathological alterations induced by acute transient and long-terra bilateral common carotid occlusion in rats[J]. Pharmacol Res,2004,49(6):143-150. YANPALLEWAR SU,HOTA D,RAI S,et al. Nimedipine attenuates biochemi-cal, behavioral and histopathological alterations induced by acute transient and long-terra bilateral common carotid occlusion in rats[J]. Pharmacol Res,2004,49(6):143-150.
7、 陈杰,全伟. 尼莫地平治疗高血压基底节区脑出血的临床疗效研究[J]. 广州医药,2014,45(2):1-3. 陈杰,全伟. 尼莫地平治疗高血压基底节区脑出血的临床疗效研究[J]. 广州医药,2014,45(2):1-3.
8、 贾建平,王树英.血管性痴呆临床诊断标准探讨[J]. 中国神经免疫学和神经病学杂志,2010,17(6):387-389. 贾建平,王树英.血管性痴呆临床诊断标准探讨[J]. 中国神经免疫学和神经病学杂志,2010,17(6):387-389.
9、 RODRíGUEZ GARCíA PL, RODRíGUEZ GARCíA D. Diagnosis of vascular cognitive impairment and its main categories[J]. Neurologia, 2012, 26(2):124-128. RODRíGUEZ GARCíA PL, RODRíGUEZ GARCíA D. Diagnosis of vascular cognitive impairment and its main categories[J]. Neurologia, 2012, 26(2):124-128.
10、 VERMEER SE, PRINS ND, DEN HEIJER T, et al. Silent brain infarcts end the risk of dementia and cognitive decline[J]. N End J Med,2003,348(17):1215-1222. VERMEER SE, PRINS ND, DEN HEIJER T, et al. Silent brain infarcts end the risk of dementia and cognitive decline[J]. N End J Med,2003,348(17):1215-1222.
11、 DEBAUN MR, ARMSTRONG FD, MCKINSTRY RC,et al. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia [J]. Blood, 2012,119(20):4587-4596. DEBAUN MR, ARMSTRONG FD, MCKINSTRY RC,et al. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia [J]. Blood, 2012,119(20):4587-4596.
12、 ZHAO J, TANG H, SUN J, et al. Analysis of cognitive dysfunction with silent cerebral infarction: a prospective study in Chinese patients[J]. Metab Brain Dis, 2012,27(1):17-22. ZHAO J, TANG H, SUN J, et al. Analysis of cognitive dysfunction with silent cerebral infarction: a prospective study in Chinese patients[J]. Metab Brain Dis, 2012,27(1):17-22.
13、 LüDERS S, ST?VE S, SCHRADER J. Prevention of vascular dementia: Evidence and practice[J]. Internist (Berl), 2012,53(2):223-231. LüDERS S, ST?VE S, SCHRADER J. Prevention of vascular dementia: Evidence and practice[J]. Internist (Berl), 2012,53(2):223-231.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录